Pioneering Gene Therapy Freed Her of Sickle Cell. Is a Cure at Hand?
The New York Times
Such treatments are extraordinarily promising and costly. Will the Biden administration commit to spending that could speed clinical trial results?
MESA, Ariz. — Helen Obando, 18 and soon to be a high school senior, nibbled french fries at a cafe and chatted about her future. Dressed in a halter top and shorts, her toenails painted turquoise, she described her plans to enroll in community college, teach hip-hop dance and become a trauma nurse someday. For most of her life, such modest dreams would have been unattainable. Helen was born with sickle cell disease. Since babyhood, she had experienced episodes of searing pain, hospitalization and organ damage, and would have been expected to die in her 40s. But in 2019 she became the first American teenager with sickle cell to be declared free of the disease six months after undergoing an experimental gene therapy meant to cure her. Her symptoms have vanished. She assures teenagers she met at a camp for children with sickle cell: “One day they can have what I had.”
The findings showed the highest mortality occurred among infants who were Black, lived in Southern states or had fetal birth defects.
As Lanzhou beef noodle soup goes from regional specialty to global attraction, I set out to find the best bowls in New York City.
As of Tuesday, 22 children and two adults had been infected, all of whom were unvaccinated, local officials said.
It’s the most energetic particle of its kind ever discovered, and scientists have no idea where it came from.
This 30-minute recipe for “Marry Me Salmon” feels special but is easy enough for a weeknight.
The internet erupted in controversy over Felisa Wolfe-Simon and colleagues’ claim of a microbe thriving on arsenic. Nearly 15 years later, she’s pursuing new research on the boundaries of life.
Once thought of as a byproduct of collard greens, brothy, complex potlikker takes on new life as a wonderful base for a Japanese staple.
The new research adds to the mysteries of the planet’s deepest interior region.
The billionaire is leading a group of investors in the unsolicited offer, which complicates the start-up’s plan to raise more money.
At cardiology conferences and diabetes meetings, doctors can’t help noticing that thin seems to be very in.
President Trump’s executive order is altering scientific exploration across a broad swath of fields, even beyond government agencies, researchers say.
After helping President Trump get elected, Elon Musk was poised to dominate the country’s A.I. policies. Then Mr. Altman sneaked into the White House.
Shock and grief rippled through the health community as lifelines for care were abruptly severed.